If you cannot view the HTML newsletter below, read it online at [webversion]
Isis Innovation   E-News

TECHNOLOGY TRANSFER FROM THE UNIVERSITY OF OXFORD

 

NO.2 OCTOBER 2006

The Isis Annual Report 2006 is now available; please see the pdf version to the right or email innovation@isis.ox.ac.uk requesting a copy.

Amongst the highlights:

  • Isis total income was £2.9m
  • Isis returned £1.4m to the University for distribution to researchers and departments
  • Four Oxford spin-out companies are now listed on the AIM market
  • Isis Enterprise has worked in 15 countries helping develop their technology transfer activities.

Yours 


Tom Hockaday, Managing Director

 

Isis on the web

Annual Report 2006



New Oxford Spin-out to Transform Surfaces

Industrial Biotechnology Company (IBC) Expands Licensing Agreement

Articles

Bird-Flu: Is it a Human Pandemic Threat
Professor George G Brownlee explains why the potential for bird flu to cause a human pandemic is undeniable and discusses the research and funding needed to overcome this threat.  

Patents in the 21st Century: Convergence at Last?
Bell & Associates, sponsors on the March 2006 OIS Meeting, explain the differences in patent practice on either side of the Atlantic.


Spin-Outs: Weaving the Threads of Success
Taking new technologies from academia to market can be a highly lucrative but challenging venture. In an article for the European Biopharmaceutical Review, Tom Hockaday gives an overview.


The Emerging Technology Transfer Market Across Europe (2)
Members of the Isis Innovation team have been travelling across Europe for the past 5 years as the demand grows for advice on technology transfer.

Use of Dendritic Cells in Vaccine Delivery and Human Embryonic Stem Cell Therapies
In March 2006 Geron Corp. entered into a worldwide exclusive licence agreement covering patent applications describing a method for generating dendritic cells from human embryonic stem cells.


Spin-Out News

We are pleased to announce another new spin-out company based on Oxford University research:

OAS Ltd
The latest spin-out company from the University of Oxford, Oxford Advanced Surfaces Ltd, plans to apply breakthrough surface science to develop bespoke materials that deliver competitive advantage to their customers.

Spin-out Portfolio Updates

 Avidex
Avidex has been acquired by the German biotech company MediGene AG. With the acquisition, MediGene diversifies and broadens its drug pipeline with candidates to treat cancer and autoimmune diseases.    


New Oxford Technology & Research

Tubercolosis (TB) Vaccine
Research at the University of Oxford has resulted in the development of the leading vaccine in clinical trials for the prevention of tuberculosis.

Wet Floor Detector
A new versatile non-contact sensor for wet floor detection that is simple, accurate and reliable.

Sensitive Gas Sensors
A new methodology has been developed based on low cost carbon based electrodes for the detection of trace quantities of toxic gases such as nitrogen dioxide and chlorine.

Antibodies to Sodium Channel Isoforms
Polyclonal antibodies have been generated which target for the first time the external pore region of different sodium channel isoforms.

Stay on top of the latest University of Oxford innovations by registering for the Isis Technology Update email.

 

Meet Isis

One of the strengths of Isis project groups is that the staff have experience of both the worlds of academia and industry.

Linda Naylor, Head of Life Sciences Group at Isis describes the Group's activities: Transferring Technology in the Life and Medical Sciences.

Isis Enterprise

Advice and Expertise in Technology Transfer from Isis Innovation

 

Oxford University Consulting

Connecting business with Oxford’s expertise

 

Isis Angels Network

The investor network for Oxford spin-outs

 

Investors in People


Events

The following are forthcoming events:

OxSEC Building a Business course
http://www.science-enterprise.ox.ac.uk/html/ activities_courses.asp

Two lectures from Emmaus Oxford:
Lecture One – November 10th 2006 “The Principles, Problems and Prospects of Stem Cell Research”
Lecture Two– February 2nd 2007“Globalisation and Polarisation - Where is the World Heading?”

Register | Contact us | Feedback | Printer Friendly | Forward

Was this e-mail forwarded to you? Isis E-News delivers periodic updates on the latest technology innovations and technology transfer news from the University of Oxford. If you would like to receive future quarterly editions - Please Register.

It is not our intent to send you unwanted e-mail. Isis Innovation E-News is an entirely permission-based opt-in service -- at some point in the past you registered to receive Isis E-News (sent quarterly). However, If you no longer wish to receive Isis E-News simply click here to unsubscribe.

To ensure delivery of this e-mail to your inbox and to enable images to load automatically in future mailings, please add innovation@isis.ox.ac.uk to your e-mail address book or safe senders list.

©2006 Isis Innovation Ltd. - University of Oxford - All Rights Reserved.
Isis Innovation Ltd, Ewert House, Ewert Place, Summertown, Oxford OX2 7SG, UK
Tel: +44 (0)1865 280830 E-mail: innovation@isis.ox.ac.uk